Emerging Treatments for Rheumatoid Arthritis: Update | Consultant360
Treatment of Juvenile Idiopathic Arthritis | Pediatric Annals
Comparative Cost-Effectiveness of Tofacitinib With Continuing Conventional Synthetic Disease-Modifying Anti-Rheumatic Drugs for Active Rheumatoid Arthritis in South Korea | Rheumatology and Therapy
JCM | Free Full-Text | Current Therapeutic Options in the Treatment of Rheumatoid Arthritis
Anti-rheumatoid drugs advancements: New insights into the molecular treatment of rheumatoid arthritis - ScienceDirect
Drugs used for arthritis. Conventional Disease Modifying Anti-Rheumatic... | Download Scientific Diagram
Traditional disease-modifying antirheumatic drugs (DMARDs) | Download Table
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update | Annals of the Rheumatic Diseases
Small Molecule DMARD Therapy and Its Position in RA Treatment | IntechOpen
Emerging Treatments for Rheumatoid Arthritis: Update | Consultant360
Medicina | Free Full-Text | Diabetes-Modifying Antirheumatic Drugs: The Roles of DMARDs as Glucose-Lowering Agents
LIST OF DMARDS USED TO TREAT RHEUMATOID ARTHRITIS | Download Table
Medicina | Free Full-Text | Diabetes-Modifying Antirheumatic Drugs: The Roles of DMARDs as Glucose-Lowering Agents
Real-world treatment patterns of rheumatoid arthritis in Brazil: analysis of DATASUS national administrative claims data for pharmacoepidemiology studies (2010–2020) | Scientific Reports
The Safety of Antirheumatic Drugs (11.02.2022)
Disease-modifying antirheumatic drug-free sustained remission in rheumatoid arthritis: an increasingly achievable outcome with subsidence of disease symptoms | Annals of the Rheumatic Diseases
Biologic Disease-Modifying Antirheumatic Drug Prescription Patterns Among Rheumatologists in Europe and Japan | springermedizin.de
Does treatment strategy influence the ability to achieve and sustain DMARD-free remission in patients with RA? Results of an observational study comparing an intensified DAS-steered treatment strategy with treat to target in
Frontiers | The Therapeutic Landscape of Rheumatoid Arthritis: Current State and Future Directions
Disease-modifying antirheumatic drugs | Download Table
Cureus | The Cost-Effectiveness of and Adherence to Disease-Modifying Antirheumatic Drug (DMARD) Therapy in Rheumatoid Arthritis Patients in a Tertiary Care Teaching Hospital in Uttarakhand, India | Article
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs | Annals of the Rheumatic Diseases
Biologic and Targeted Synthetic DMARD Utilization in the United States: Adelphi Real World Disease Specific Programme for Rheumatoid Arthritis | Rheumatology and Therapy
Biologic and Targeted Synthetic DMARD Utilization in the United States: Adelphi Real World Disease Specific Programme for Rheumatoid Arthritis | Rheumatology and Therapy
Rheumatoid Arthritis: Aggressive New Treatment Guidelines
EULAR points to consider for the management of difficult-to-treat rheumatoid arthritis | Annals of the Rheumatic Diseases
